Metagenomi Therapeutics Inc
(MGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 20,008 | 11,159 | 12,399 | 12,363 | 11,337 |
| Gross Profit | 20,008 | 11,159 | 12,399 | 12,363 | 11,337 |
| Operating Expenses | 36,871 | 40,191 | 32,595 | 34,758 | 29,300 |
| Operating Income | -16,863 | -29,032 | -20,196 | -22,395 | -17,963 |
| Other Income | 3,925 | 3,884 | 3,628 | 3,781 | 6,853 |
| Pre-tax Income | -12,938 | -25,148 | -16,568 | -18,614 | -11,110 |
| Income Tax | -2,199 | N/A | 2,726 | 1,206 | 1,898 |
| Net Income Continuous | -10,739 | -25,148 | -19,294 | -19,820 | -13,008 |
| Net Income | $-10,739 | $-25,148 | $-19,294 | $-19,820 | $-13,008 |
| EPS Basic Total Ops | -0.29 | -1.19 | -5.67 | -5.82 | -3.82 |
| EPS Basic Continuous Ops | -0.29 | -1.19 | -5.67 | -5.82 | -3.82 |
| EPS Diluted Total Ops | -0.29 | -1.19 | -5.67 | -5.82 | -3.82 |
| EPS Diluted Continuous Ops | -0.29 | -1.19 | -5.67 | -5.82 | -3.82 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -1.19 | N/A | N/A | N/A |
| EBITDA(a) | $-17,611 | $-29,010 | $-20,703 | $-23,704 | $-19,762 |